Effects of dose escalating liraglutide from 1.2 to 1.8 mg in clinical practice: a case–control study
Crossref DOI link: https://doi.org/10.1007/s40618-015-0385-5
Published Online: 2015-09-02
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rigato, M.
Avogaro, A.
Fadini, G. P.
Text and Data Mining valid from 2015-09-02
